AVODAGEN is structured around processing capability categories: upstream sourcing, Korean processing, analytical verification, and documentation. Specific molecule availability is discussed during qualified partner engagement.
Peptide intermediate sourcing from GMP-compliant manufacturers with FDA registration and EU regulatory standing. Material enters the operating model only after supplier qualification.
GMP-compliant manufacturers with FDA registration, EU regulatory standing, and clean inspection history. Evaluation performed against documented qualification criteria before commercial engagement.
Incoming intermediates verified at the Korean processing partner facility before processing proceeds: identity confirmation, purity verification, documentation review, and chain of custody initiation.
Preparative purification, lyophilization, and quality release at the ISO 9001 certified Korean partner facility. Real value-add chemistry, not transhipment.
Preparative HPLC and downstream purification workflows performed at the ISO 9001 certified Korean partner facility. Designed to elevate intermediates through documented Korean processing standards.
Lyophilization and finished material conditioning performed at qualified Korean processing partners. Workflow is structured around documented batch records, in-process controls, and yield analysis.
Process chemistry performed at ISO 9001 certified Korean partner with documentation discipline. Substantial transformation principles drive the operational design.
Meaningful Korean value-add chemistry, equipment, and processing labor performed at the Korean partner facility. The Korean processing layer is operational, not nominal.
Quality release coordination through Korean processing partner quality systems with documented batch records, deviation handling, and release criteria.
Korean processing batch records, in-process controls, yield analysis, and processing deviations documented through KORECOA platform integration.
Independent verification through accredited Korean laboratory partnership. Third-party documentation distinct from supplier or processor self-certification.
Verification through accredited Korean laboratory partners: validated methods, traceable measurement standards, third-party audit. Independent of supplier and processor.
Standard release panel: HPLC purity and identity, mass spectrometry confirmation, water content, endotoxin testing, residual solvents, heavy metals.
KORECOA consolidates supplier qualification, processing records, accredited results, and origin documentation into a single verifiable package with batch-level traceability.
Supplier qualification, regulatory standing references, active filings, and inspection records.
Korean processing batch records from ISO 9001 certified partner, in-process controls, yield analysis, and deviation records.
Accredited release panel results with chain of custody and method validation documentation.
Certificate of origin documentation, substantial transformation records, and trade documentation.
Standard offering: research-grade peptide and bioactive material from Korean infrastructure. Pharmaceutical-grade by custom development for qualified partners by request. Availability and pricing confirmed after verification.
Research-use material at greater than 99 percent purity with accredited Korean Certificate of Analysis and KORECOA batch certificate. For qualified research peptide companies, biotech R&D, CROs, and academic institutions. Research use only.
Custom pharmaceutical-grade engagements are available for qualified institutional partners by request, involving additional supplier qualification, processing controls, and documentation appropriate to the intended use. Scope and documentation are confirmed during qualification.
Material supplied at greater than 99 percent purity with accredited Korean verification. Listed molecules are for reference. Availability and pricing released after qualification. Research use only.
Additional research peptides, custom synthesis, and pharmaceutical-grade development engagements available to qualified business accounts by request.
Reference identification constants. Values shown are net-peptide / free-base. Batch-specific Technical Data Sheets and COAs released after qualification. Research use only.
| Code | Molecule | CAS No. | Formula | MW (Da) | Capability Category | Pathway | Status |
|---|---|---|---|---|---|---|---|
| NB-MA-0101 | Semaglutide | 910463-68-2 | C187H291N45O59 | 4113.64 | Metabolic Agonists | Metabolic Regulation | Verified |
| NB-MA-0102 | Tirzepatide | 2023788-19-2 | C225H348N48O68 | 4813.45 | Metabolic Agonists | Metabolic Regulation | Verified |
| NB-AR-0201 | BPC-157 | 137525-51-0 | C62H98N16O22 | 1419.55 | Angiogenesis & Tissue Repair | Angiogenesis | Verified |
| NB-AR-0202 | TB-500 (Thymosin β-4) | 77591-33-4 | C212H350N56O78S | 4963.44 | Angiogenesis & Tissue Repair | Angiogenesis | Verified |
| NB-AR-0203 | GHK-Cu | 89030-95-5 | C14H22CuN6O4 | 403.93 | Angiogenesis & Tissue Repair | Tissue Remodeling | Verified |
// Identification constants cross-checked against authoritative chemical registries. For molecules outside our core verified catalog, submit an institutional inquiry via our Qualified Partner channel for custom synthesis and targeted processing. All material supplied For Research Use Only. Business Account Verification Required.
Operational discipline defines the portfolio as much by exclusion as inclusion. Research-use material for qualified partners only.
Molecules under active clinical trial sponsor protection are outside operating scope. AVODAGEN does not source, list, or quote molecules where third-party sponsors maintain trial-stage exclusivity.
AVODAGEN engages exclusively at the active ingredient and intermediate layer. Finished injectable preparations, compounded products, and other finished dose forms are outside operating scope. Compounding pharmacies and finished drug manufacturers are the licensed parties for finished preparation.
AVODAGEN supplies qualified business and institutional partners with verified business registration only. Research use only. Not for direct consumer sale. Business account verification, documentation review, and signed terms of supply required before commercial engagement.
Qualified partners may request capability-specific commercial discussions including processing scope, lead time, batch size, supplier qualification documentation, analytical workflow, and documentation framework.
Request Qualified Partner Access →